Court Rules
All enforcement actions
SettlementHigh Risk

NJ Division of Consumer Affairs Fines Virtua Medical Group $417K for HIPAA Violations

Virtua Medical Group, P.A.April 4, 2018New Jersey Attorney General

Penalty Amount

$417,816

Consumers Affected

1,654

Summary

Virtua Medical Group agreed to pay $417,816 and implement a corrective action plan to settle allegations that it failed to properly secure electronic protected health information (ePHI). A vendor's server misconfiguration publicly exposed the medical records of over 1,650 patients via Google searches. The New Jersey Division of Consumer Affairs found VMG violated HIPAA's Security and Privacy Rules by not adequately vetting the vendor's security and failing to conduct proper risk analysis.

Remedy

VMG must pay $417,816 in civil penalties and fees. It must hire a third-party to conduct a thorough security risk analysis of ePHI storage, transmission, and receipt, submitting reports to the Division within 180 days and annually for two years. The Corrective Action Plan mandates improved data security practices and vendor oversight.

Monetary PenaltyCompliance ProgramAudit Requirement

Contract Impact

In-house legal teams should immediately review all vendor and business associate agreements, particularly those involving third-party service providers that handle sensitive data like medical transcriptions or cloud storage. Specific clauses to scrutinize include security requirements (encryption, access controls), mandatory risk assessment obligations, breach notification timelines and procedures, audit rights for compliance verification, and data retention/destruction terms. Given this enforcement action, agreements may need strengthening to require vendors to provide regular security certifications (e.g., SOC 2), implement mandatory security training, and include explicit indemnification for data breaches caused by vendor negligence. For customer or partner agreements, ensure data processing addendums incorporate HIPAA-level safeguards and clearly allocate liability for third-party mishandling of protected information.

Contract Search Terms

business associate agreementrisk assessment clausesecurity requirements specificationbreach notification procedureaudit rights provisiondata encryption standardvendor management policyHIPAA compliance certificationincident response plandata retention schedule

Laws Cited

Health Insurance Portability and Accountability Act (HIPAA) Security RuleHealth Insurance Portability and Accountability Act (HIPAA) Privacy RuleNew Jersey Consumer Fraud Act

Violation Types

Entity Details

Entity

Virtua Medical Group, P.A.

Also known as: Virtua Medical Group

Industry

Healthcare

Official Sources

Source Evidence

Entity Name
"Virtua Medical Group, P.A. (“VMG”)"
Fine Amount
"pay $417,816"
Violation Types
"violated the federal Health Insurance Portability and Accountability Act’s (HIPAA) Security Rule"
Violation Types
"publicly exposed the medical information – including patient names, medical diagnoses and prescriptions"
Violation Types
"VMG was not aware of the source of the information viewed by the daughter because Best Medical Transcription had not notified them of the security breach"
Laws Cited
"Health Insurance Portability and Accountability Act’s (HIPAA) Security Rule"

Related Enforcement Actions

NJ

Trump Administration

A multistate coalition co-led by New Jersey won a federal court order rejecting the Trump Administration’s decision not to request funding for the CFPB. The order struck down that decision and directed the Administration to follow the law and fund the agency; no monetary penalty or privacy violation is described.

NJ

Mitragynine pseudoindoxyl, MGM-15, and MGM-16

New Jersey’s Attorney General and Division of Consumer Affairs alerted the public that three synthetic kratom-related compounds became illegal to possess or sell in the state under a temporary federal scheduling order. The release describes a controlled-substance alert, not a privacy enforcement action, and identifies no company, privacy violation, or monetary penalty.

NJ

Laboratory Corporation of America Holdings (LabCorp)

$2.3M

Laboratory Corporation of America Holdings agreed to pay $2,287,455 to participating states and strengthen its security and vendor-management practices following an investigation into the 2019 breach at its debt-collection vendor, AMCA. The breach potentially exposed information of more than 27.5 million people nationwide, including sensitive information belonging to approximately 10.2 million LabCorp patients.

NJ

Credit Acceptance Corporation (CAC)

$694.0M

New Jersey's Attorney General and Division of Consumer Affairs, along with 41 Attorneys General, reached a $694 million settlement with subprime auto lender Credit Acceptance Corporation over allegations it originated unaffordable loans its own systems predicted borrowers could not repay, employed aggressive debt-collection tactics, and failed to prevent deceptive vehicle-service contract and GAP product 'packing' by dealers. The multistate settlement stepped in after the CFPB permanently dropped its 2023 enforcement action against CAC in 2025. CAC will provide $60 million in cash restitution, $634 million in debt relief, an additional $15 million to the states, and implement injunctive lending reforms including loan off ramps, pre-loan disclosures, add-on packing safeguards, and a seven-year vehicle price cap. Note: this is a consumer-protection lending enforcement action, not a privacy matter; violation categories are best-fit mappings from the available taxonomy.

NJ

Match Group, Inc.

$650K

The New Jersey Attorney General and Division of Consumer Affairs announced that Match Group, Inc. will pay $650,000 and change its business practices to settle allegations that it misrepresented or failed to disclose its criminal background screening policies and practices to New Jersey users, violating the New Jersey Consumer Fraud Act and the Internet Dating Safety Act. Under a Consent Order, Match must accurately represent its screening policies, notify existing New Jersey members of updated disclosures within 150 days, and post clear and conspicuous disclosures and safety notifications about the limitations of criminal background screenings.

NJ

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

$96.5M

New Jersey and a coalition of states and territories obtained preliminary approval for a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to raise drug prices. The settlements total approximately $96.5 million, and eligible consumers may submit claims for compensation.